- Home
- HSTM vs KALV Comparison
HSTM vs KALV Comparison
Compare HSTM & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- KALV
- Stock Information
- Founded
- HSTM 1990
- KALV N/A
- Country
- HSTM United States
- KALV United States
- Employees
- HSTM N/A
- KALV N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- HSTM Technology
- KALV Health Care
- Exchange
- HSTM Nasdaq
- KALV Nasdaq
- Market Cap
- HSTM 864.6M
- KALV 796.4M
- IPO Year
- HSTM 2000
- KALV N/A
- Fundamental
- Price
- HSTM $26.95
- KALV $10.97
- Analyst Decision
- HSTM Hold
- KALV Strong Buy
- Analyst Count
- HSTM 2
- KALV 8
- Target Price
- HSTM $28.00
- KALV $26.43
- AVG Volume (30 Days)
- HSTM 191.3K
- KALV 1.5M
- Earning Date
- HSTM 10-20-2025
- KALV 09-11-2025
- Dividend Yield
- HSTM 0.46%
- KALV N/A
- EPS Growth
- HSTM 14.03
- KALV N/A
- EPS
- HSTM 0.67
- KALV N/A
- Revenue
- HSTM $295,211,000.00
- KALV $1,426,000.00
- Revenue This Year
- HSTM $4.90
- KALV N/A
- Revenue Next Year
- HSTM $5.12
- KALV $213.43
- P/E Ratio
- HSTM $40.24
- KALV N/A
- Revenue Growth
- HSTM 3.50
- KALV N/A
- 52 Week Low
- HSTM $25.36
- KALV $7.30
- 52 Week High
- HSTM $34.24
- KALV $17.28
- Technical
- Relative Strength Index (RSI)
- HSTM 35.07
- KALV 32.68
- Support Level
- HSTM $27.04
- KALV $11.93
- Resistance Level
- HSTM $27.94
- KALV $12.04
- Average True Range (ATR)
- HSTM 0.56
- KALV 0.56
- MACD
- HSTM -0.29
- KALV -0.21
- Stochastic Oscillator
- HSTM 1.09
- KALV 10.10
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.